Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Roytman M, Kim S, Glynn S, Thomas C, Lin E, Feltus W, et al. PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes. Front Oncol. 2021;11:820287.

Akgul M, Williamson SR, Ertoy D, Argani P, Gupta S, Caliò A, et al. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. J Clin Pathol. 2021;74(5):291-299.

Wang SA, Ok CY, Kim AS, Lucas F, Morgan EA, Thakral B, et al. Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations. Am J Hematol. 2021;96(11):E420-E423.

Wang W, Chen R, Droll S, Barber E, Saleh L, Corrigan-Cummins M, et al. miR-181c regulates MCL1 and cell survival in GATA2 deficient cells. J Leukoc Biol. 2021.

Shah RB, Cai Q, Aron M, Berney DM, Cheville JC, Deng F-, et al. Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations. Am J Cancer Res. 2021;11(8):3990-4001.

Labrecque MP, Brown LG, Coleman IM, Lakely B, Brady NJ, Lee JK, et al. RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer. Cancer Res. 2021;81(18):4736-4750.

Mahdi Z, Ettel MG, Gonzalez RS, Hart J, Alpert L, Fang J, et al. Metastases can occur in cirrhotic livers with patent portal veins. Diagn Pathol. 2021;16(1):18.

Cesarman E, Chadburn A, Rubinstein PG. KSHV/HHV8-mediated hematologic diseases. Blood. 2021.

Stonesifer CJ, Trager MH, Magro CM, Geskin LJ. CD8+ Lymphogranulomatous Dermatitis as a Manifestation of Malignancy-Associated Immunodeficiency: Rethinking Paraneoplastic Granulomas. Am J Dermatopathol. 2021;43(12):e222-e226.

Iyengar NM, Zhou XK, Mendieta H, Giri DD, El-Hely O, Winston L, et al. Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer. Cancer Prev Res (Phila). 2021;14(5):541-550.